Diagnosed Prevalent Cases of Chronic Heart Failure to Reach 32 Million
Nearly 40% of all diagnosed prevalent cases of Chronic Heart Failure (CHF) in the eight major markets (8MM*) occur in the elderly population, and this is estimated to increase by a further 40% by 2028. The major drivers for this trend include increasing life expectancy, early diagnosis of heart failure (HF) by improved screening and detection of HF, as well as the widespread adoption of effective treatment strategies to manage HF patients with multiple comorbidities.
GlobalData’s latest report, Heart Failure – Epidemiology Forecast Report to 2028, states that diagnosed prevalent cases of chronic heart failure (CHF) in the 8MM are projected to increase from 26.8 million in 2018 to 32.2 million in 2028, at an annual growth rate (AGR) of 2.02%. There were 12.8 million cases of the disease in China in 2018, which represented 47.69% of those in the 8MM. The UK had the lowest number of diagnosed prevalent cases in 2018 at 5.50 million.
Arunkumar N.V, MPH, Epidemiologist at GlobalData, said “The substantial increase in comorbidities, such as coronary artery disease (CAD) and hypertension, may be driving the number of diagnosed prevalent cases to rise in the elderly. It is observed that HF with preserved ejection fraction (PEF) is one of the common cardiac complications of longstanding hypertension. In 2018, the 8MM saw more than half of CHF patients experience CAD or hypertension as a major comorbid condition.
Despite advancements in the treatment of CHF, the major unmet needs in elderly CHF patients are improved adherence to treatment guidelines and additional effective therapeutic options to manage CHF with multiple comorbidities.
Arunkumar N.V, concludes “The improvement of screening techniques and diagnostic approaches over the years has led to better diagnoses, as reflected in the increased burden of CHF. Effective strategies to prevent lifestyle diseases such as hypertension and diabetes mellitus during early adulthood may help prevent the occurrence of CHF in the elderly”
*8MM: The US, France, Germany, Italy, Spain, the UK, Japan and China
To gain access to our latest press releases: GlobalData Media Centre
Analysts available for comment. Please contact the GlobalData Press Office:
Email: pr@globaldata.com
EMEA & Americas: +44 (0)207 832 4399
Asia-Pacific: +91 40 6616 6809
To gain access to our latest press releases and expert analysis on developments in your industry, please connect with us on:
GlobalData.com | LinkedIn | Twitter
4,000 of the world’s largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make more timely and better business decisions thanks to GlobalData’s unique data, expert analysis and innovative solutions, all in one platform. GlobalData’s mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors.
Total Page Views: 1544